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ABSTRACT
It is time to bring our imagination, creativity and passion to the fore in solving the global challenges of our age.
Our global health crisis and the pandemic of noncommunicable diseases (NCDs) is clearly rooted in complex
modern societal and environmental changes, many of which have effects on developing immune and metabolic
responses. It is intimately related to wider environmental challenges. And it is unsurprising that many NCDs
share similar risk factors and that many are associated with a rising predisposition for inflammation. Allergy is
one of the earliest signs of environmental impact on these biological pathways, and may also offer an early ba-
rometer to assess the effects of early interventions. There is dawning awareness of how changing microbial di-
versity, nutritional patterns, sedentary indoor behaviours and modern pollutants adversely affect early meta-
bolic and immune development, but still much to understand the complexity of these interactions. Even when
we do harness the science and technology, these will not provide solutions unless we also address the wider
social, cultural and economic determinants of health - addressing the interconnections between human health
and the health of our environment. Now more than ever, we need a wider vision and a greater sense of collec-
tive responsibility. We need long-range approaches that aim for life long benefits of a ‘healthier start to life’, and
stronger cross-sectoral collaborations to prevent disease. We need to give both our hearts and our minds to
solving these global issues.
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This is not a comprehensive review. Nor is it an up-to-
date review. It is not even a balanced perspective of
the topic. In fact, to my great delight, I have been in-
structed to completely ignore that conventional ap-
proach, and to focus on my personal experiences, my
struggles and even my failed efforts in developing pri-
mary prevention strategies for allergic disease.
First though, I will take the liberty of redefining the
scope of this agenda, as I believe it is critically impor-
tant to consider the ‘allergy epidemic’ in the context
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Fig.　1　The interconnections between human health and environmental health. Humans are af-
fecting the ‘health’ of the planet with adverse effects on our own health.
of the much wider pandemic of noncommunicable
diseases (NCDs).1 It would be shortsighted to con-
sider these as separate or unrelated, and quite
against my personal philosophies. Many of modern
diseases share the same lifestyle and environmental
risk factors, and I strongly believe that we should be
taking a more interdisciplinary, cross-sectoral ap-
proach if we ever hope to overcome these major
global health issues.1 We also need to see that the hu-
man health crisis is intimately linked with the declin-
ing health of our environment (Fig. 1).
For over 20 years I have been keenly interested in
the ‘developmental origins of health and disease’
known as ‘DOHaD’, which was initially grounded in
cardiovascular medicine. And although I might be
better known for my research in allergy, my work has
been inherently interdisciplinary for many years.
So why has a paediatrician and an immunologist
with a focus on allergic disease been so intrigued by
these ideas about the ‘early origins’ of adult heart dis-
ease? Why had I even been following this literature in
the 1980s, in an era before the true dawn of interdisci-
plinary research?
PREVENTION IS IMPERATIVE IN THE FACE
OF OUR GLOBAL HEALTH CRISIS
Before I get to my own philosophies and the journey
of my work in disease prevention, I want to emphasis
the enormous scale of the NCD pandemic and the
need for a global response to the a global health cri-
sis. ‘Modern lifestyle’ diseases are now recognized as
the leading cause of death worldwide, in both devel-
oped and developing countries. This global health cri-
sis has been building, slowly, silently, and deadly―
yet largely unheeded for decades. NCDs are a major
cause of poverty and must be viewed as a major
global economic threat. In 2011, in response to this
global health crisis, the United Nations (UN) General
Assembly held its first high-level summit specifically
to address the rising worldwide burden of NCDs.
This has bought the issue squarely into the global po-
litical agenda, with participation of Heads of State and
Governments from around the world. Based on the
sobering figures presented in the UN Political Decla-
ration on the ‘Prevention and Control of NCDs’, there
are more than 36 million deaths each year from
NCDs.2 These chronic diseases account for more
than 60 per cent of all global deaths. Tragically, at
least 9 million of all preventable NCD deaths are in
younger people, in their ‘prime’ years of life. An as-
tounding 80% of all NCD related deaths occur in the
developing, underprivileged regions of the globe.2
Without urgent action it has been projected that
NCDs will claim the lives of 52 million annually by
2030. Even in Africa, NCDs are also projected to well
surpass infectious diseases as the most common
cause of death by 2030. No region, no population is
unaffected.
There is no doubt that this epidemic is hitting the
developing world and lower income populations hard-
est. While poverty and lack of education are major
risk factors for NCDs, NCDs also drive both individu-
als and economies further into poverty, creating a vi-
cious cycle. It is clear that this cycle can only be bro-
ken by addressing the social and economic determi-
nants of health. This underscores the compelling
need for a multilateral ‘whole-of-Government’ ap-
proach.
Prevention is clearly the name of this game. It is
stamped all over the global strategic plan. But, amaz-
ingly, the dominant focus has largely been on ‘adult’
interventions for NCDs, which are still seen largely
as ‘problems of adulthood’. Given what we know now,
this still limited, shorter-term approach is neither sus-
tainable, nor as likely to succeed as a more compre-
hensive ‘life course’ strategy that addresses all stages
of life and specifically targets ‘early life’ the most logi-
cal period for true preventive intervention. If preven-
tion is to be more effective, it is obvious that strate-
gies need to be implemented before disease processes
are initiated and before risk factors come into play.
With clear evidence that the pathways and risk fac-
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tors that lead to many NCDs begin to have effects
very early in development, this should be a core ele-
ment in the agenda and strategic plan. But it has not
been.
By its very nature, such an approach immediately
throws a spotlight on the central importance of educa-
tion and health literacy in children, adolescents and
parents, and in particular the need to educate and em-
power women of childbearing age in all regions of the
world. I was privileged to play a very small part in an
effort to address this need, through the World Uni-
versities Network (WUN), which met in Shanghai in
2011, with the task of developing a simple clear and
unequivocal declaration to be delivered to the United
Nations, ahead of the General Assembly. The result-
ing Shanghai Declaration3 was an opportunity to
stress the social and economic benefits of low cost in-
terventions applied early in the ‘life course’, and all
the wider benefits of strengthening the basic human
right to a healthy start to life, education and gender
equity. It also endorsed a multi-agency approach syn-
ergistically linked to current programmes on mater-
nal and child health, infectious disease and to the Mil-
lennium Development Goals. Small fragments of this
were adopted into the UN Political Declaration on the
‘Prevention and Control of NCDs’2 but many believe
that the importance of early intervention was not em-
phasized nearly enough.
THE ‘EARLY ORIGINS’ OF MY RESEARCH
When I first came to the allergy field in the early
1990’s I was already well schooled in concepts of pre-
vention. As a paediatrician, this was second nature.
But through my research earlier in the 1980’s, I was
also very familiar with the notions that nutrition, life-
style and other environmental factors play a funda-
mental role in disease predisposition. Although I am
now well known in the ‘allergy world’, few are aware
that I actually started my research career in cardio-
vascular medicine, and that my first randomized con-
trolled trial (RCT) was actually studying the effects of
nutrition on blood pressure.4,5 In those days I was
working in a group that were in the process of discov-
ering the anti-inflammatory properties of diet nutri-
ents.6,7 It was also at a time when there was dawning
recognition that cardiovascular disease (CVD) was an
‘inflammatory’ disorder rather than simply a mechani-
cal narrowing of vessels secondary to cholesterol
deposition. Macrophages and their cytokines had be-
gun to feature as likely mediators in pathogenesis of
atherosclerosis. At almost the same time there was a
similar paradigm shift in the field of asthma. As a
medical student I had learned about asthma as a re-
versible, mechanical narrowing of airways, with the
emphasis very much on aberrant smooth muscle re-
sponses and neural reflexes. However, in the 1980s
we also began to ‘inflammation’ take a more central
role in our understanding of the pathogenesis of
asthma. By extension, this also became the dominant
focus of treatment, as inhaled corticosteroids became
more widely used in the control of the disease
through reducing airways inflammation.
In 1986, through the cardiovascular field, I began
to learn more about the ‘early life origins’ of heart dis-
ease and other chronic inflammatory diseases.8 David
Barker’s group had just published a Lancet paper sug-
gesting strong geographical variations in ischaemic
heart disease in England and Wales might be linked
to impaired fetal growth and nutrition in pregnancy.8
Much higher rates of coronary heart disease were
seen in poorer rural or industrial areas where infant
mortality had been also been highest. They proposed
that the same ‘in utero’ risk factors for infant mortal-
ity were also risk factors for poor fetal growth the sur-
vivors, and that this poor early nutrition might be the
contributing risk factor for later heart disease in the
region. This was consistent with earlier reports in the
1970s by Norwegian researchers who had also noted
higher rates of CVD in regions of high poverty.9 Both
groups proposed that early nutritional deficits lead to
permanent damage, and that later affluence was a
prerequisite for disease. It seemed that the risk was
greatest if there was significant ‘mismatch’ between
the anticipated environment based on our ‘in utero’
experience and what actually happens after birth. For
example, if we encounter an overabundance of food
after birth when our metabolism has been pro-
grammed for scarcity, we are more prone to disease.
Without detailed data on birth weights and infant
growth this was largely conjecture at that point.
That same year, one of the postdocs from our
group, Barrie Margetts, who had also been working
on the RCT of dietary interventions on blood pres-
sure, moved to Southampton in the UK to work with
Barker on the Hertfordshire cohort in an attempt to
confirm this association. It was this link that drew my
attention when they went on to their next Lancet pa-
per on the ‘early life origins of disease’ in 1989.10 In
Hertfordshire they found the ideal opportunity to
map long-term disease outcomes in relation to early
growth and development. From 1911 onwards the
midwives and health visitors had recorded birth
weight and visited homes to measure infant weights.
Follow-up of over 5,000 men born between 1911 and
1930 revealed that the risk of coronary heart disease
was proportionally higher as birth weight decreased.
This appeared to confirm Barker’s earlier theory that
in utero stress and poor nutrition increased the future
risk of CVD. In the years that followed they also pub-
lished evidence that adult lung function, chronic lung
disease, obesity, diabetes risk and other noncommu-
nicable diseases (NCDs) are similarly related to early
nutrition, birth weight and other early life events.
The same is true of virtually all body systems. It is
very obvious now that ‘adverse conditions’ in early
life can have lasting effects on all aspects of growth
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Fig.　2　A rising propensity for infl ammation is implicated in 
the parallel rise of virtually all NCDs. This suggests a central 
role of the immune system, as one possible nexus for multi-
system effects of modern environmental changes.
and development. These very early effects on both
structure and function, shape our physiological (func-
tional), immune, metabolic, and even psychological
and behavioural response patterns to the environ-
ment and can have life-long effects. Most importantly,
this can influence the susceptibility to diseases dec-
ades later. On the flip side, it is logical that promoting
‘optimal conditions’ in early life is the best hope we
have of hardwiring ‘healthy’ physiological, structural,
immune, metabolic, and behavioural response pat-
terns in order to prevent so many avoidable diseases.
One of the best-known examples of this is how fetal
growth patterns can influence the risk of heart dis-
ease, obesity and type 2 diabetes in later life. And
there are many more examples.
These concepts provided a strong grounding for
my research as I specialized in paediatric immunol-
ogy and allergy, and as I became increasingly inter-
ested in inflammation as a common linking theme un-
derpinning many of these NCDs. For me it also
raised the likelihood that many of the environmental
risk factors shared by NCDs may exert at least some
of their effects through effects on the developing im-
mune system.
EARLY IMMUNE PROGRAMMING - A COM-
MON PATHWAY TO NCDs?
From 1995 I worked with renowned cell biologist Pat-
rick Holt, mapping early immune development in hu-
mans. By 1999 we had published our own Lancet pa-
per,11 which turned the spotlight onto the ‘early ori-
gins’ of allergy and immune diseases. This was the
first to map very early immune responses over the
first years of life and to find early differences in chil-
dren with allergic inflammation. Some of these differ-
ences were already apparent at birth, providing evi-
dence of ‘fetal programming’ of allergic disease and
fueling interest in much earlier events.12 Differences
in the very early postnatal maturation of immune re-
sponses also indicated the importance of events in
the first months of life. As with the ‘Barker story’, this
contributed to a significant shift in thinking towards
the ‘early origins’ of allergic disease. In some ways
this was an easier case to sell than the ‘early origins’
of heart disease. Because eczema, food allergy and
asthma appear so much earlier in life it is more obvi-
ous that early events must be important.
The allergy epidemic is the clearest evidence we
have that the early immune system is exquisitely sen-
sitive to modern environmental changes. And I could
not help wondering if the same environmental risk
factors might be implicated in the rise in so many
other inflammatory diseases. Given that diet, mi-
crobes, exercise and modern pollutants all affect the
developing immune system, it can be no surprise that
these are also linked with the rise in so many other
NCDs.
And for this reason, when I set up my own inde-
pendent research team in 1999, my primary focus
was on trying to demonstrate that a number of spe-
cific early in the environmental factors, such as ma-
ternal diet, smoking and early microbial exposure
have at least some of their effects on the developing
immune system.13-17 It is certainly becoming clearer
that the developing immune system is exquisitely vul-
nerable system to early environmental changes, and
has a central role in the risk of so many different dis-
eases.1
In 2001, the International DOHaD Society officially
was founded and the very first international congress
was held in Mumbai. In true interdisciplinary spirit,
this bought together experts from diverse fields of
medicine and science, all with a common goal: pro-
moting the importance of a ‘healthy start to life’, be-
ginning from (and even before) conception, for the
future health of all body systems and as the best hope
for preventing diseases later in life. I was invited to
‘represent’ the immune system and allergy. At that
time I was not really sure that many people under-
stand the relevance of what I was doing. But attend-
ing that first DOHaD meeting made it even clearer to
me that the immune system is a core part of the
wider NCD story. My early research into heart dis-
ease taught me a lot about the role of the ‘inflamma-
tion’ in hypertension and cardiovascular disorders. In
fact, it has become increasingly obvious that inflam-
mation is a common element of most NCDs, includ-
ing heart disease, lung disease, joint disease, bowel
disease, diabetes and obesity related diseases (Fig.
2). There was little doubt in my mind that modern en-
vironmental changes promote inflammation and, as a
paediatrician, I could already see the first hand ef-
fects of this in the first years of life in the epidemic al-
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Fig.　3　The allergy epidemic as a canary in the coal mine. 
An early indicator of the impact of modern environmental 
change and specifi c vulnerability of the immune system. This 
early propensity for infl ammation and immune dysregulation 
has implications for rising risk many other later onset infl am-
matory diseases (NCDs).
lergic inflammation. I decided that I would keep try-
ing to get that point across. As you might imagine,
with so many parallel sessions, the allergy and immu-
nity session was tucked away and did not compete
well with the sessions on cardio-metabolic disease, so
I did not get to sell my message to many people.
Since then, there has been mounting evidence that
the immune system plays an important role in the de-
velopmental programming of many organ systems,
and the predisposition to many diseases. It is also
clear that the early environment heavily influences
the ‘dynamics of inflammation’ in later life (below).18
Even in the brain, there is now good evidence that
the immune system plays a critical role in the estab-
lishment of synaptic networks in the developing
brain,19,20 and that the balance of cytokine levels in
the hippocampus is important for learning and mem-
ory.21 Early life events can alter response patterns of
microglial (the innate immune cells of the brain) to
inflammatory challenges in later life will increase the
risk of inflammation and a range of neuropsychiatric
disorders, many of which have been linked to in-
creased inflammatory cytokine production.20-24 This
is really to illustrate the point that improving ‘immune
health’ in early life may achieve a great deal more
than just preventing allergy and immune disease, but
is likely to have benefits for many other developing
organ systems, and our future predisposition to many
other diseases as well.
THE ALLERGY EPIDEMIC AS AN IMPOR-
TANT SIGNPOST
There is every indication that allergic diseases are
rapidly rising in almost all developing regions, and it
is estimated that already, around 30-40% of the
world’s population are affected by one or more of
these allergic conditions with vast personal, social
and economic costs.25 But a key and important differ-
ence is that allergic diseases appear much earlier in
life than other NCDs. Allergic diseases are arguably
are the only common NCDs to appear in the first year
of life, with children bearing the brunt of the very dra-
matic recent rise in disease. This indicates that the
developing immune system is particularly sensitive to
environmental changes. Many will have heard me re-
fer to allergy as ‘the canary in the coal mine’ (Fig. 3).
By extension, this means that the immune system is
a useful early barometer of environmental impact, and
an early measure of effectiveness of any interventions
that we might try to prevent disease―not just allergy
but other NCDs. So why is allergy not on the global
NCD agenda?
Those of us working in this field can very easily see
that many environmental risk factors influence im-
mune function, including maternal diet, maternal
smoking, maternal stress and early microbial expo-
sures. We can see how changes in diet can specifi-
cally alter immune function in the gut with implica-
tions not just for immune diseases, but also diabetes,
heart disease, obesity and even neurological disor-
ders. The immune system is designed to respond
quickly to the environment. That is how we survive.
This may also be the reason that modern environ-
ment changes lead to symptoms of immune disease
so early in life. This can offer us vital clues about why
we are also increasingly prone to other NCDs, which
all generally feature inflammation and immune dys-
regulation.
The dominant focus of the NCDs agenda is usually
on ‘the big four’ - cardiovascular disease, metabolic
disease (obesity and type 2 diabetes), cancer and
chronic lung disease. While both asthma and smok-
ing related disease are considered in the context of
‘chronic lung disease’, allergic diseases per se are
typically overlooked in this agenda, despite now be-
ing the most common and the earliest onset NCDs in
most regions. This multi-disciplinary alliance is at the
very core of how we need to move forward with a
more integrated interdisciplinary vision of human
health. It is now important to broaden this agenda,
and that other extremely common NCDs and their
risk factors are progressively incorporated into the
agenda―not as competing interests but a part of a
bigger picture, which reveals the inter-relationships
between these conditions and may help us under-
stand the pathways to disease better.
TARGETING INFLAMMATORY PATHWAYS
TO PREVENT A RANGE OF DISEASES
Economic prosperity is associated with a rising pro-
pensity for chronic low-grade inflammation, and ris-
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Fig.　4　Many life style risk factors for NCDs have both immune and metabolic effects. These are 
also the logical targets to prevention infl ammation and metabolic dysregulation.
ing susceptibility the chronic inflammatory NCDs.
The environmental conditions in utero and in early
childhood also appear to contribute to the risk of sub-
sequent inflammatory diseases.18 This includes both
early onset NCDs such as allergy, asthma and some
autoimmune diseases, as well as later onset NCDs in-
cluding cardiovascular disease, metabolic disease and
neurodegenerative disorders - which appear to share
many common environmental risk factors.1 While in-
flammation and the pathways to disease are clearly
multifactorial, dietary changes, pollution and declin-
ing microbial diversity are central themes, and in-
creasingly implicated in the immune and metabolic
dysregulation seen in many NCDs26 (Fig. 4).
The role of the early environmental and inflamma-
tion is obvious in allergy, but low-level chronic inflam-
mation, even at levels previously thought to be incon-
sequential, appears to contribute to many NCDs and
diseases of aging18 including cardiovascular disease27
and type 2 diabetes.28 Even in childhood, early arte-
rial changes that predict atherosclerosis can be read-
ily detected.29,30 The cardiovascular research team I
still collaborate with have shown that a strikingly
high proportion of Australian 14 year olds show in-
flammatory and metabolic changes that predict car-
diovascular disease and other NCDs.31 There is also
emerging literature in the allergy field, showing that
IgE levels are linearly related to BMI (body mass in-
dex) and CRP in children.32
These observations are also consistent with evi-
dence that both baseline levels of CRP in adulthood
and the ‘dynamics of inflammation’ are influenced by
the early life environment.18 This includes a wide
range of nutritional and microbial exposures, environ-
mental toxins, and maternal health factors including
obesity, gestational diabetes, preeclampsia (high
blood pressure) in pregnancy and a range of other
factors and stressors that can influence both growth
and inflammation. The interrelationships between
metabolic health and immune health are recurring
themes and major determinants of disease risk.
While the global NCD agenda has tended to focus
on ‘the big four risk factors’ (poor nutrition, tobacco,
alcohol and lack of exercise) this overlooks the vital
role of the microbiome which is now known to play a
critical role in both metabolic and immune program-
ming.1,26 This has been of longstanding interest in
the field of allergy where the hygiene hypothesis
originally emerged,33 but the role of the microbiome
in metabolic health has only emerged relatively re-
cently.34-37 The high fat, low fibre ‘western’ diet is
now understood to adversely change the gut micro-
biome, with associated effects on gut barrier function,
increasing systemic antigenic load and low-grade en-
dotoxaemia - as a driving factor for insulin resistance,
obesity, and diabetes.38 This is associated with in-
creased CRP and higher levels of circulating IL-1β,
TNF, IL-6 and adiponectin as evidenced by increased
low-grade systemic inflammation.39 Microbiota can
also directly regulate host genes involved in lipid me-
tabolism34 with associated effects insulin resistance,
food craving, altered lipid profiles and liver function,
which collectively contribute to obesity and metabolic
dysregulation.34-37 Notably, many of these physiologi-
cal and metabolic adaptations can be reversed
through restoring a more ‘favourable’ gut micro-
biome.37
Using the brain as another example, because it is
often overlooked in this discussion, we can see that
as the main immune cells of the brain, microglia are
very sensitive to any inflammatory triggers in the sys-
temic circulation. They are able to detect the same
broad range of ‘danger signals’ as other immune
cells, including microbial signals and non-microbial
Towards a New Age of Disease Prevention
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danger signals. These can be in the external environ-
ment or ‘alarmins’ that are released from damaged
tissues and inflammation within the body.40 This all
means that the microglia may be potentially re-
programmed by a range of other inflammatory events
early in life, to modify developing brain function. In
this context we also see new dimensions to the ‘gut-
brain’.41-44 Most researchers in the field of allergy are
very familiar with the highly quoted studies of Sudo
and colleagues in germ free mice45; which demon-
strate the failure of immune development and the de-
velopment of immune diseases when normal gut colo-
nization is prevented or delayed. But they are gener-
ally less familiar with the effects that Sudo’s team
showed on the developing brain.41 Essentially, in
germ-free animals showed reduced expression of the
neuronal growth factor BDNF in the cortex and hip-
pocampus, and heightened cortisol stress re-
sponses,41 consistent with patterns seen in depres-
sion and anxiety. This shows that without normal bac-
teria, ‘germ free’ animals develop not only immune
and metabolic dysregulation, but also maladaptive
changes in brain function and in regulation of the
HPA axis. Critically, these effects can all be reverse
by either giving probiotic bacteria, or by ‘faecal trans-
plant’ from a normally colonized mouse.41 Critically,
and just as for immune development, timing was criti-
cal―reversal was only possible at an early stage of
development. Once the responses patterns become
established with age, they cannot be readily changed.
This is consistent with what we know about ‘critical
early periods’ for both immune and neural develop-
ment and the declining plasticity of neural networks
with age. Even in mature animals, disrupting the es-
tablished normal gut flora with antibiotics can result
in changes in BDNF in the brain and altered behav-
iour.43
In this light we need to address the many lifestyle
factors promote chronic inflammation, and these ap-
pear to contribute to significantly higher baseline lev-
els of inflammation. There is a very strong case for
promoting ‘immune health’ as an integral part of
NCD prevention. Now more than ever, these notions
underscore the need for a more integrated, interdisci-
plinary approach in collectively addressing these
problems, which have all arisen in response to mod-
ern environmental conditions. It seems to be so bla-
tantly obvious that strategies that promote early im-
mune and metabolic homeostasis, will reduce the
risk of cardiovascular disease, diabetes, obesity, neu-
ropsychiatric disorders, allergy and other immune
diseases, and many other NCDs.
I could now launch into a discussion of all the usual
culprits in the allergy epidemic, how we might ad-
dress them, and what the evidence is at present. And
there are many reviews that do just this every year,
including ones I have written.1 I even wrote a whole
book about it.46 So, I am not going to trawl through
all that here. We all know the main broad risk factors:
changing microbial diversity, changing dietary pat-
terns, changing lifestyles (more indoor, sedentary be-
havior and stress), more environmental toxins and
pollutants (Fig. 4). Every discipline would probably
list the same risk factors for its major NCDs focus.
This covers quite a lot of potential risk factors and we
also know it is hard to separate the relative effects of
each of these. Animal models confirm metabolic and
immunological effects of almost all of these potential
factors and in many cases we can only extrapolate
this to humans. In other cases the evidence is more
compelling.
But how much evidence do we need to be able to
see that smoking, unhealthy food, physical inactivity
and environmental pollution are bad for our health?
How much evidence do we need that declining biodi-
versity and declining environmental health is ad-
versely affecting human health? And why, for allergy
in particular, are we so slow to make recommenda-
tions and propose change?
SO WHY IS THIS SO HARD TO SOLVE?
Albert Einstein said ‘The world is a dangerous place to
live; not because of the people who are evil, but because
of the people who don’t do anything about it.’ Taking re-
sponsibility at both the individual and the societal
level is essential for to address our global health chal-
lenges. Inertia is our greatest enemy in this. The first
critical step in solving any problem of such magni-
tude is to recognise it, acknowledge it and collectively
agree that action is needed. This needs a very broad-
based collaborative effort, at every level of our com-
munities. The ‘health’ sector needs to engage more
widely, because most of the underlying ‘causes’ of the
NCD pandemic do not lie within the traditional do-
mains of ‘health’. It is critical to address the much
wider social, cultural and economic determinants of
health (the ‘causes of the causes’).47
At the highest levels, the 2011 United Nations Dec-
laration on the Control and Prevention of NCDs2 has
been of pivotal importance in recognizing that ‘the
global burden and threat of NCDs constitutes one of
the major challenges for development in the twenty-
first century’, and for taking a multilateral stand on
this.
Even this initial step, before any solutions are
posed, can take considerable time and effort. We ex-
perienced the decades of inertia before efforts to ad-
dress global warming and the environmental crisis
began in earnest. Lack of acknowledgement and lack
of consensus were largely to blame, in no small part
due to sabotage from self-interested parties. Now that
we recognize the mistakes we have made with the
delicate health of our planet, it is important that we
don’t make the same mistakes with our own health.
There are frightening parallels. Again, we have to
contend with sabotage from serious villains - Big To-
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Fig.　5　A signifi cant component of NCD risk is programmed early in life and early exposures 
have the greatest long term consequences. Our challenge is to overcome the effects of urbaniza-
tion as the major culprit in the NCD pandemic, by targeting the early environment.
Fig.　6　Time is of the essence. Prevention must begin in 
early life but it is never too late to choose a brighter future.
bacco. There is absolutely no doubt that smoking
kills, costs billions every year and drives economies
further into poverty. Yet it continues. An industry
built on addicting youth and promoting chronic ill
health and disease still thrives. We face other threats;
from the Food and Drink Industry, contributing to
damaging levels of fat, sugar, salt and ‘fast’ food con-
sumption. It was not that long ago that cigarettes and
soda drinks were openly and blatantly advertised as
healthy. Now tactics are slightly more subtle. But
while we can ban tobacco, we can’t ban food, and a
more challenging, collaborative approach with indus-
try will be needed to overcome those threats. As with
global warming, before any action can be taken, a
global consensus is needed.
The global NCD political agenda has also been fun-
damental for making real progress towards a unified
vision for health, including firm measures towards ad-
dressing the major risk factors for NCDs. However,
while is recognised that a large proportion of NCDs
are inherently preventable, the prevailing approaches
focusing on adult interventions are far less effective
than early life approaches. While the vision of pro-
moting heath in early life is more logical in the long-
term, this still too commonly overlooked. It is now es-
sential that we make every effort to promote a greater
awareness of the importance of a ‘life-course’ ap-
proach for disease prevention, beginning with strate-
gies to promote maternal health, both before and af-
ter conception (Fig. 5).
Albert Einstein also said ‘We cannot solve our prob-
lems with the same thinking we used when we created
them’. Like so many of our other global challenges,
our NCD pandemic may be a crisis of our making,
but we have the power to overcome it. But only if we
stand together and be prepared to take a new ap-
proach. If we don’t, it will surely be our undoing. This
all needs to begin with a greater awareness and ‘buy-
in’ through our communities, our health systems and
our governments. Fortunately this is an idea that is
coming of age, and there is gathering momentum
around these concepts. We might be turning the cor-
ner, but we need to be realistic about how far and
how long this will take, and not lose enthusiasm in
the process. We need to be in this for the long haul.
GETTING TO THE HEART OF THE MATTER
This might not have been what the Journal had in
mind when they extended me these liberties, but
these kinds of discussions rarely find a home in sci-
entific journals and I congratulate them for taking
this vision. In the spirit of what they might have in-
tended, I will return to the ‘immune system’ and
some scientific questions that we need to consider in
preventing NCDs, allergy included. Could the im-
mune system be a common link between many of the
NCDs? Are the effects of many of the environmental
risk factors mediating their effects (at least in part)
through immune effects? Are some of the differences
in genetic (and racial) susceptibility to NCDs medi-
ated through genetic polymorphisms in immune
pathways and inflammatory responses? Regardless of
the mechanisms, lifestyle and environmental inter-
ventions that reduce inflammation are likely to have
benefits for the risk and progression of many NCDs.
Towards a New Age of Disease Prevention
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There is a very strong case for promoting immune
health as an integral part of NCD prevention. Now
more than ever, these notions underscore the need
for a more integrated, interdisciplinary, cross-sectoral
approach in collectively addressing these problems,
which have all arisen in response to modern environ-
mental conditions.
In closing, I really hope to appeal to the heart and
humanity in all of us, at every level and in every walk
of life. Because in the end, it is the passion and con-
viction of our inspiration that brings about change.
For too long we have allowed a hard, cold dispassion-
ate view to dominate. Where ‘issues’ and ‘problems’
have been stripped of their true human dimension.
We truly have to get to the ‘heart’ of the matter!
There is absolutely nothing to loose and everything
to gain. And we might feel even ‘healthier’ and hap-
pier just by thinking this way. We are at a fork in the
road and it is not too late to choose a brighter future
(Fig. 6). Our leaders are committed, and this is the
time to express our commitment as individuals.
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